Pristimerin enhances the effect of cisplatin by inhibiting the miR-23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells

Lung cancer is a common type of cancer with a high mortality rate in China. Cisplatin (Cis) is one of the most effective broad-spectrum chemotherapeutic drugs for the treatment of advanced lung cancer. However, Cis resistance remains an obstacle in the treatment of advanced lung cancer. Pristimerin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yingbing, Wang, Jiquan, Hui, Beina, Sun, Wenze, Li, Bin, Shi, Fan, Che, Shaomin, Chai, Linyan, Song, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365073/
https://www.ncbi.nlm.nih.gov/pubmed/30664149
http://dx.doi.org/10.3892/ijmm.2019.4057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365073/
https://www.ncbi.nlm.nih.gov/pubmed/30664149
http://dx.doi.org/10.3892/ijmm.2019.4057

Ejemplares similares